Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas
- PMID: 2721500
- PMCID: PMC400870
- DOI: 10.1002/j.1460-2075.1989.tb03434.x
Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas
Abstract
We have compared proviral integrations near (putative) proto-oncogenes in Moloney murine leukemia virus-induced primary and transplanted T cell lymphomas. We previously found proviruses integrated near c-myc, pim-1, and N-myc in primary tumors (Selten et al., 1984; Van Lohuizen et al., 1989a; Van Lohuizen et al., 1989b). We have now identified an additional common proviral integration site, called pim-2, that carries somatically acquired proviruses in the majority of transplanted tumors. In primary tumors integration near pim-2 is usually undetectable or present in only a minor fraction of the tumor cells. This subpopulation selectively grows out upon transplantation. Insertion near pim-2 is a relatively late event in tumorigenesis and is often preceded by proviral insertions in other common insertion sites, yielding tumor clones which carry proviruses in up to three different common insertion sites within the same cell (c-myc, pim-1 and pim-2). The data suggest that pim-2 plays an important role in tumor progression.
Similar articles
-
Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.J Virol. 1997 Jan;71(1):9-16. doi: 10.1128/JVI.71.1.9-16.1997. J Virol. 1997. PMID: 8985317 Free PMC article.
-
Activation of multiple genes by provirus integration in the Mlvi-4 locus in T-cell lymphomas induced by Moloney murine leukemia virus.J Virol. 1990 May;64(5):2236-44. doi: 10.1128/JVI.64.5.2236-2244.1990. J Virol. 1990. PMID: 1691313 Free PMC article.
-
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation.EMBO J. 1984 Dec 20;3(13):3215-22. doi: 10.1002/j.1460-2075.1984.tb02281.x. EMBO J. 1984. PMID: 6098468 Free PMC article.
-
Transgenic mice as a means to study synergism between oncogenes.Int J Cancer Suppl. 1989;4:22-5. doi: 10.1002/ijc.2910440706. Int J Cancer Suppl. 1989. PMID: 2681009 Review.
-
Tumorigenesis in transgenic mice: identification and characterization of synergizing oncogenes.J Cell Biochem. 1991 Oct;47(2):130-5. doi: 10.1002/jcb.240470206. J Cell Biochem. 1991. PMID: 1661736 Review.
Cited by
-
PIM3 Kinase: A Promising Novel Target in Solid Cancers.Cancers (Basel). 2024 Jan 26;16(3):535. doi: 10.3390/cancers16030535. Cancers (Basel). 2024. PMID: 38339286 Free PMC article. Review.
-
Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.J Hematol Oncol. 2013 Jan 29;6:12. doi: 10.1186/1756-8722-6-12. J Hematol Oncol. 2013. PMID: 23360755 Free PMC article.
-
Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.J Mol Med (Berl). 2012 Jun;90(6):681-93. doi: 10.1007/s00109-011-0848-x. Epub 2011 Dec 29. J Mol Med (Berl). 2012. PMID: 22205266
-
Downregulation of Pim-2 induces cell cycle arrest in the G0/G1 phase via the p53-non-dependent p21 signaling pathway.Oncol Lett. 2018 Apr;15(4):4079-4086. doi: 10.3892/ol.2018.7865. Epub 2018 Jan 26. Oncol Lett. 2018. PMID: 29541172 Free PMC article.
-
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.Blood. 2014 Feb 6;123(6):905-13. doi: 10.1182/blood-2013-04-495366. Epub 2013 Dec 20. Blood. 2014. PMID: 24363397 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases